A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES AND AML. Report from the American Society of Hematology (ASH) Annual Meeting, December 10–13, 2022

被引：0

作者：

机构：

来源：

memo - Magazine of European Medical Oncology | 2023年 / 16卷 / Suppl 2期

关键词：

D O I：

10.1007/s12254-023-00883-4

中图分类号：

学科分类号：

摘要：

引用

页码：29 / 52

页数：23

共 14 条

[1] A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 11–14, 2021
[J]. memo - Magazine of European Medical Oncology, 2022, 15 (Suppl 2) : 13 - 35
[2] A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES. Report from the American Society of Hematology (ASH) Annual Meeting, December 9–12, 2023
[J]. memo - Magazine of European Medical Oncology, 2023, 16 (Suppl 12) : 197 - 225
[3] A GLOBAL CONGRESS DIGEST ON TARGETED THERAPIES IN B-CELL MALIGNANCIES Report from the European Hematology Association (EHA) 2024 Congress (hybrid), 13th – 16th June 2024
[J]. memo - Magazine of European Medical Oncology, 2024, 17 (Suppl 2) : 37 - 60
[4] Highlights in B-Cell Malignancies From the 61st American Society of Hematology Annual Meeting: Commentary
Furman, Richard R.
[J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (02) : 24 - 26
[5] Highlights of the Annual Meeting of the American Society of Hematology (ASH). December 10-13, 2011, San Diego [Höhepunkte der jahrestagung der American Society of Hematology (ASH): 10. bis 13. Dezember 2011, San Diego]
Junker A.
[J]. Der Onkologe, 2012, 18 (3): : 265 - 268
[6] Report from the virtual American Society of Hematology (ASH) Annual Meeting, December 5th–8th, 2020
[J]. memo - Magazine of European Medical Oncology, 2021, 14 (Suppl 1) : 1 - 22
[7] A GLOBAL CONGRESS DIGEST ON TARGETED AND IMMUNE-DIRECTED THERAPIES IN HAEMATOLOGICAL MALIGNANCIES. Report from the American Society of Clinical Oncology (ASCO) Annual Meeting (hybrid), 2nd–6th June 2022, and the 30th European Hematology Association (EHA) 2022 Congress (hybrid), 9th–12th June 2022
[J]. memo - Magazine of European Medical Oncology, 2022, 15 (Suppl 7) : 123 - 144
[8] Bispecific antibodies as monotherapy or in combinations for non-hodgkin B-cell lymphoma: latest updates from the American society of hematology 2022 annual meeting
Lin, Zhijuan
Liu, Long
Li, Zhifeng
Xu, Bing
[J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2023, 12 (01)
[9] Bispecific antibodies as monotherapy or in combinations for non-hodgkin B-cell lymphoma: latest updates from the American society of hematology 2022 annual meeting
Zhijuan Lin
Long Liu
Zhifeng Li
Bing Xu
[J]. Experimental Hematology & Oncology, 12
[10] Novel CAR T-cell therapies for relapsed/refractory B-cell malignancies: latest updates from 2023 ASH annual meeting
Zhang, Wenjie
Li, Sumei
Long, Jinlan
Xie, Shufeng
Wang, Minghui
Liu, Han
Xu, Zhenshu
[J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)

← 1 2 →